Juho Markku Jalkanen
Founder at FARON PHARMACEUTICALS OY
Net worth: 3 M $ as of 30/05/2024
Network origin in Juho Markku Jalkanen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 31 | |
University of Turku
4
| College/University | Other Consumer Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Juho Markku Jalkanen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| WOLFSPEED, INC. | Semiconductors | Director/Board Member | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor | |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Director of Finance/CFO | |
| HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chief Executive Officer Founder | |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Investment Managers | Corporate Officer/Principal Founder | |
| The University of Edinburgh | College/University | Director/Board Member Doctorate Degree | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Helsinki | College/University | Corporate Officer/Principal Graduate Degree | |
Juno Therapeutics GmbH
 Juno Therapeutics GmbH BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Juno Therapeutics GmbH is a German company that researches and develops cellular therapies. The company is based in Munich, Germany. The CEOs of the company are David Walter Pignolet, Lothar Germeroth. Juno Therapeutics was acquired by Juno Therapeutics, Inc., part of Bristol Myers Squibb Co. from March 07, 2018 on May 11, 2015 for $232.80 million. | Biotechnology | Chief Executive Officer | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of North Alabama | College/University | Director/Board Member | |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
Gardant Pharmaceuticals, Inc.
 Gardant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Gardant Pharmaceuticals, Inc. develops and commercializes pharmaceutical compounds. It develops network for research, clinical development, and project management and guides them through the clinical development and licensing stages. The company was founded in 2000 and is headquartered in New York, NY | Pharmaceuticals: Major | Chief Executive Officer | |
Delta Communications, Inc.
 Delta Communications, Inc. Specialty TelecommunicationsCommunications Delta Communications, Inc. supplies data communications products and systems. The company was founded in 1973 and headquartered in Waukesha, WI. | Specialty Telecommunications | Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Celgene Ltd.
 Celgene Ltd. Pharmaceuticals: MajorHealth Technology Celgene Ltd. engages in the development of human pharmaceuticals and agrochemicals. It focuses on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. The company was founded on June 2, 2015 and is headquartered in Uxbridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Chairman | |
KNOW Bio LLC
 KNOW Bio LLC Pharmaceuticals: MajorHealth Technology KNOW Bio LLC engages in the development and optimization of a nitric oxide platform providing therapies that focuses on curing diseases and conditions. The company was founded in 2015 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chief Executive Officer | |
Novoclem Therapeutics
 Novoclem Therapeutics Pharmaceuticals: MajorHealth Technology Novoclem Therapeutics develops inhalable treatments for antibiotic-resistant pathogens found in patients with cystic fibrosis and other respiratory diseases. The private company is based in Durham. | Pharmaceuticals: Major | Chief Executive Officer | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Director/Board Member | |
| VECTURA GROUP | Pharmaceuticals: Major | Director/Board Member | |
Aerami Therapeutics Holdings, Inc.
 Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Dance Biopharm Holdings, Inc. engages in providing health care services. The company was founded by John Stuart Patton in 2010 and is headquartered in San Francisco, CA. | Medical Specialties | Chief Executive Officer | |
Sanofi US Services, Inc.
 Sanofi US Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi US Services, Inc. engages in the research, production and distribution of pharmaceutical products. The company is based in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
Celgene International SARL
 Celgene International SARL Pharmaceuticals: MajorHealth Technology Founded in 2010, Celgene International SARL is a Swiss bio-pharmaceutical company that operates to discover, develop, and commercialize therapies for unmet medical needs in cancer. Part of Bristol Myers Squibb Co., the company is based in Boudry, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Touchlight Genetics Ltd.
 Touchlight Genetics Ltd. BiotechnologyHealth Technology Touchlight Genetics Ltd. operates as a biotechnology company. It develops an enzymatic means of DNA scale production addresses the limitations of plasmid DNA and meets the growing demands of DNA revolution. It offers DNA enables therapeutics, direct DNA therapeutics, and DNA nanotechnology. The company was founded by jonny Ohlson in 2008 and is headquartered in Hamptonl, the United Kingdom. | Biotechnology | Director/Board Member | |
Leniobio GmbH
 Leniobio GmbH Miscellaneous Commercial ServicesCommercial Services Leniobio GmbH is a German protein expression platform company that focuses on the discovery, development, and large-scale production of proteins. The company was established in September 2016 and has offices in Dusseldorf and R&D and production labs in Aachen. Leniobio is redefining biopharma manufacturing and believes in providing equal opportunities for everyone to lead a healthy life. The company was founded by Remberto Martis, and André Goerke has been the CEO since 2023. | Miscellaneous Commercial Services | Director/Board Member | |
| Nogra Pharma Invest SARL | Director/Board Member | ||
| ORION OYJ | Pharmaceuticals: Major | Director/Board Member | |
| Emil Aaltosen Säätiö | Director/Board Member | ||
Suomalainen Tiedeakatemia Ry
 Suomalainen Tiedeakatemia Ry Miscellaneous Commercial ServicesCommercial Services Suomalainen Tiedeakatemia Ry is a Finnish learned society founded in 1908 with the aim of promoting scientific research and serving as a link between researchers representing high-level science. The private company is based in Helsinki, Finland, and its office is located at Mariankatu 5 A, 3rd floor, 00170 Helsinki. The office is open from Monday to Friday from 8 am to 4 pm. | Miscellaneous Commercial Services | Chairman | |
| National Institute For Health & Welfare | Corporate Officer/Principal | ||
| Tampere University of Technology | College/University | Director/Board Member |
Statistics
International
| United States | 18 |
| Finland | 10 |
| United Kingdom | 7 |
| Germany | 4 |
| Sweden | 3 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 6 |
| Commercial Services | 5 |
| Electronic Technology | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 135 |
| Corporate Officer/Principal | 56 |
| Chairman | 42 |
| Independent Dir/Board Member | 30 |
| Chief Executive Officer | 28 |
Most connected contacts
- Stock Market
- Insiders
- Juho Markku Jalkanen
- Company connections
